Expressions of matrix metalloprotainese-2 and metalloprotainese-9 in human breast cancer cell line MDA-MB-435s with high- and low-metastatic potentiality
|更新时间:2026-01-09
|
Expressions of matrix metalloprotainese-2 and metalloprotainese-9 in human breast cancer cell line MDA-MB-435s with high- and low-metastatic potentiality
Journal of Army Medical UniversityVol. 33, Issue 6, Pages: 600-603(2011)
Zhang Tao,Chen Xiaopin,Tang Weixue,Peng Zhiping,Li Shaolin.Expressions of matrix metalloprotainese-2 and metalloprotainese-9 in human breast cancer cell line MDA-MB-435s with high- and low-metastatic potentiality[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(06):600-603.
Zhang Tao,Chen Xiaopin,Tang Weixue,Peng Zhiping,Li Shaolin.Expressions of matrix metalloprotainese-2 and metalloprotainese-9 in human breast cancer cell line MDA-MB-435s with high- and low-metastatic potentiality[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(06):600-603.DOI:
Expressions of matrix metalloprotainese-2 and metalloprotainese-9 in human breast cancer cell line MDA-MB-435s with high- and low-metastatic potentiality
Objective To establish the subclones of MDA-MB-435s human breast cancer cells with high and low potentiality of metastasis
and then investigate the differences of the expressions of matrix metalloprotainese-2 and -9 (MMP-2 and MMP-9) between these 2 subclones. Methods Transwell invasion assay was used to screen the subclones of MDA-MB-435s cells with high- and low- metastatic potentiality. The expressions of MMP-2 and MMP-9 were examined with immunohistochemical staining and Western blot analysis
and cell invasion ability was evaluated Transwell invasion assay. Results Transwell invasion assay showed the ivasion ability of breast cancer cells was higher in the cells with high-metastatic potentiality than those with low-metastatic potentiality
with significant difference (P0.05). Immunohistochemistry showed that the expression levels of MMP-2 and MMP-9 were significantly higher in cells with high metastatic potentiality (0.24±0.04 and 0.23±0.05 respectively) than that in cells with low metastatic potentiality (0.16±0.02 and 0.13±0.03 respectively
P0.05). These results were confirmed by Western blot assay. A positive correlation was found between the expression levels of MMP-2/9 and the invasion potentiality of MDA-MB-435s (r=0.957
0.964
P0.05). Conclusion The subclones of human breast cancer cells with high- and low- metastatic potentiality can be screen with Transwell invasion assay. Tumour cells to penetrate a matrigel barrier in vitro is closely related with the expression levels of MMP-2 and MMP-9 in human breast cancer cells.